Boston Advisors’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $1.17M | Buy |
1,266
+481
| +61% | +$445K | 0.06% | 359 |
|
|
2019
Q2 | $887K | Sell |
785
-3
| -0.4% | -$3.39K | 0.05% | 386 |
|
|
2019
Q1 | $1.07M | Sell |
788
-2
| -0.3% | -$2.72K | 0.05% | 330 |
|
|
2018
Q4 | $914K | Buy |
790
+615
| +351% | +$712K | 0.05% | 334 |
|
|
2018
Q3 | $266K | Sell |
175
-448
| -72% | -$681K | 0.01% | 584 |
|
|
2018
Q2 | $975K | Buy |
623
+81
| +15% | +$127K | 0.02% | 378 |
|
|
2018
Q1 | $626K | Buy |
542
+40
| +8% | +$46.2K | 0.02% | 455 |
|
|
2017
Q4 | $595K | Sell |
502
-7,543
| -94% | -$8.94M | 0.01% | 469 |
|
|
2017
Q3 | $10.8M | Buy |
8,045
+1,045
| +15% | +$1.41M | 0.25% | 120 |
|
|
2017
Q2 | $5.65M | Buy |
+7,000
| New | +$5.65M | 0.13% | 196 |
|
|
2016
Q3 | – | Sell |
-789
| Closed | -$324K | – | 685 |
|
|
2016
Q2 | $324K | Buy |
789
+209
| +36% | +$85.8K | 0.01% | 586 |
|
|
2016
Q1 | $309K | Buy |
580
+4
| +0.7% | +$2.13K | 0.01% | 574 |
|
|
2015
Q4 | $439K | Buy |
+576
| New | +$439K | 0.01% | 488 |
|